United Arab Emirates Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

  • Published : Aug 2022
  • Report Code : KSI061613422
  • Pages : 90

United Arab Emirates infection control market is evaluated at US$55.668 million for the year 2020 and is projected to grow at a CAGR of 6.54% to reach a market size of US$86.706 million by the year 2027.

The steady population growth compared to 2017, the Dubai Emirate had 3,080,165 residents in 2018. To cater to healthcare needs, there has been significant growth in the number of physicians and human resources. The registered physicians in Dubai were 8,901 in 2018, with an increase of 57.9% from 2011 and an increase of 2.4% in 2017. The share of primary health care services is 18.4%, and specialized centres are 1.4% of the total. Demand for health services grew higher during the last few years. This was driven by a significant increase in outpatient encounters, as 10,864,076 outpatient visits were recorded during the year 2018, showing a 3.3% increase from that of 2017. The rate of daily visits was 14.3 visits/per 1000 population.

The Private Health Sector (PHS) represented more than 3-quarters of these visits (78.3%), while the share of Dubai Health Authority was near to one-quarter (20%). Thus, translating to achieving public/private partnership goals in health services provision reached more than the Ratio of 20% Vs.80% share respectively and achieved Dubai health strategic goals. The number of inpatients in Dubai was 355,327 in 2018, provided through 30 private and six governmental hospitals, with an increase of 17.2% in inpatients in 2017. The annual discharge rate was 115.4 per 1000/per population.

The total bed occupancy rate (BOR) for the Emirate was 54.5%. The number of patients’ days of care was 938,911, with a (16%) increase in total days of care in 2016 [Source: Dubai Annual Health Statistical Report].  Therefore, the aforesaid facts and figures, along with burgeoning expenses that are borne by the government along with expenses from the private pocket that contributes to the expenditure mix, to extend various healthcare offerings will require further investments in infection control products to prevent any healthcare-associated infection (HCAI). Thereafter providing the thrust to the clinical infection control market of UAE during the forecast period.

Another segment poised to push infection control market growth in UAE to a new zenith during the forecast period is that of medical tourism and its consequent influence on the hospitality sector through food and beverage as well as accommodation establishments. 

To this end, it may be noted that Health Tourism is a space where the UAE government has put a special emphasis when His Highness Sheikh Hamdan Bin Mohammed Bin Rashid Al Maktoum, Crown Prince of Dubai and Chairman of the Dubai Executive Council, approved the Dubai Health Tourism Strategy, with Dubai Health Authority (DHA) overseeing its execution. Thus, to position Dubai as a globally recognized destination for elective health and wellness treatments, the Health Tourism Council- DHA was formed. Furthermore, the number of overseas patients was 1,207 in 2018. The UK sought overseas treatments by the highest proportion of patients (28.3%), followed by German (25.9%), then followed by Thailand (15.8%), then the USA (6.9%). In the first place, oncology treatments were sought by (25.4%) of the total overseas patients. Orthopedic surgery was sought by (10.8%), and after that, ophthalmology, 7.6%, and neurology & neurosurgeries were responsible for 6.7% of cases treated overseas, respectively. The average cost was 274.3 thousand Dirhams per patient. [Source: Dubai Annual Health Statistical Report]. Considering the growth of medical tourism thus the influx of patients from foreign countries, the need for establishments providing food and beverage as well as accommodations and, the need for new healthcare points as well as the imperative of legacy healthcare providers to observe and adhere to strict infection prevention measures have emerged as paramount importance. Therefore, the demand for the infection prevention products that will be set in motion by both these symbiotic sectors (healthcare and tourism) is projected to galvanize the infection control market of UAE to unprecedented heights during the forecast period.

Recent development and expansions

In May 2022, the BD (Becton, Dickinson, and Company) Dubai branch looks forward to addressing today's healthcare challenges and discussing solutions that can be used to implement better strategies and practices that can drastically reduce on-site infections, human error, and other safety risks for patients and frontline workers alike. With modern MedTech breakthroughs, BD remains committed to ushering the region into a new era of healthcare by improving medical discovery, diagnostics, and care delivery.

COVID-19 impact on United Arab Emirates Infection Control Market

The UAE has a comprehensive, government-funded health service as well as private health facilities that provide the population with high-quality health care. During the pandemic, the entire healthcare system was prepared and alerted, with protocols in place to handle the crisis efficiently. The UAE government carried out a comprehensive public awareness campaign that targeted various segments of the community and provided a daily update on the disease's status both locally and globally. Testing services were promptly provided in most healthcare facilities across the UAE, and drive-through testing centres were established by the Department of Health - Abu Dhabi and SEHA for the convenience of testing. These facilities were outfitted with the most advanced testing systems, techniques, and equipment.
Emiratis, domestic workers in Emirati households, people of determination, pregnant women, residents over the age of 50, people with chronic diseases, those with coronavirus symptoms, and all contacts of coronavirus patients received free tests. Field hospitals were established in the UAE to relieve pressure on city-based hospitals and to facilitate a quicker response to COVID-19. In handling and managing cases, all of these facilities adhered to strict COVID -19 protocols.

United Arab Emirates Infection Control Market Scope:

 

Report Metric Details
 Market Size Value in 2020  US$55.668 million
 Market Size Value in 2027  US$86.706 million
 Growth Rate  CAGR of 6.54% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Million
 Segments Covered  Product, And End-User Industry
 Companies Covered 3M, ASP., Merck Serono Middle East FZ-Ltd. (Merck KGaA), Cardinal Health, Tuttnauer
 Customization Scope  Free report customization with purchase

 

Market Segmentation

  • By Product
    • Disinfectants
    • Sterilization
      • Low-Temperature Sterilization
      • Heat Sterilization
      • Contract Sterilization
  • By End-User Industry
    • Healthcare
    • Food and Beverage
    • Chemical

1. INTRODUCTION
1.1. Market Overview
1.2. Covid-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY
3.1. Research Highlights

4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.4. Industry Value Chain Analysis

5. UAE INFECTION CONTROL MARKET, BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low-temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization

6. UAE INFECTION CONTROL MARKET, BY END-USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical

7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix

8. COMPANIES MENTIONED
8.1. 3M
8.2. ASP. 
8.3. Merck Serono Middle East FZ-Ltd. (Merck KGaA)      
8.4. Cardinal Health  
8.5. Tuttnauer

3M

ASP.

Merck Serono Middle East FZ-Ltd. (Merck KGaA)      

Cardinal Health  

Tuttnauer